Dawnrays Pharmaceutical (Holdings) (HKSE:02348) Total Current Assets : HK$2,351 Mil (As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dawnrays Pharmaceutical (Holdings) Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Dawnrays Pharmaceutical (Holdings)'s total current assets for the quarter that ended in Dec. 2024 was HK$2,351 Mil.

Dawnrays Pharmaceutical (Holdings) Total Current Assets Historical Data

The historical data trend for Dawnrays Pharmaceutical (Holdings)'s Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dawnrays Pharmaceutical (Holdings) Total Current Assets Chart

Dawnrays Pharmaceutical (Holdings) Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Current Assets

Get a 7-Day Free Trial

1,835.90

1,850.21

1,947.55

1,881.51

2,351.27

Dawnrays Pharmaceutical (Holdings) Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Current Assets	Get a 7-Day Free Trial															1,947.55	1,816.40	1,881.51	2,401.28	2,351.27

Dawnrays Pharmaceutical (Holdings) Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Dawnrays Pharmaceutical (Holdings)'s Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1457.795	+	544.753	+	329.1	+	19.623
	=	2,351

Dawnrays Pharmaceutical (Holdings)'s Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1457.795	+	544.753	+	329.1	+	19.623
	=	2,351

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Dawnrays Pharmaceutical (Holdings) (HKSE:02348) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Dawnrays Pharmaceutical (Holdings)'s Liquidation Value for the quarter that ended in Dec. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1457.795	-	728.801	+	0.75 * 130.574	+	0.5 * 329.1
=	991

Dawnrays Pharmaceutical (Holdings) Total Current Assets Related Terms

Thank you for viewing the detailed overview of Dawnrays Pharmaceutical (Holdings)'s Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Dawnrays Pharmaceutical (Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dawnrays Pharmaceutical (Holdings) Ltd (HKSE:02348) » Definitions » Total Current Assets

Traded in Other Exchanges

N/A

Address

338 Hennessy Road, Units 3001-02, 30th Floor, CNT Tower, Wanchai, North Sea Centre, Hong Kong, HKG

Website

https://www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Ltd is a drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth plan.

Executives

Li Kei Ling
Hung Yung Lai
Fortune United Group Limited	2101 Beneficial owner
Hunwick International Limited	2201 Interest of corporation controlled by you
Keysmart Enterprises Limited	2201 Interest of corporation controlled by you
Iu Pun	2202 Interest of your spouse
Li Tung Ming
Fmr Llc	2201 Interest of corporation controlled by you
Toyo International Investment Limited
Leung Hong Man
Leung Yiu Sing
Chu Shuet Fong
Lo Mei Sai
Time Lead Investments Limited

Dawnrays Pharmaceutical (Holdings) Headlines

No Headlines